The mechanisms of hypercalciuria are unnecessary for treatment of recurrent renal calcium stone formers.
D001581:Benzothiadiazines; D002118:Calcium / Q000652:urine*; D002136:Calcium, Dietary / Q000008:administration & dosage; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D000242:Cyclic AMP / Q000378:metabolism; D004232:Diuretics; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000209:etiology / Q000628:therapy*; D008297:Male; D010281:Parathyroid Hormone / Q000378:metabolism; D010710:Phosphates / Q000627:therapeutic use; D012306:Risk; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
D001581:Benzothiadiazines; D002136:Calcium, Dietary; D004232:Diuretics; D010281:Parathyroid Hormone; D010710:Phosphates; D049993:Sodium Chloride Symporter Inhibitors; D002482:Cellulose; C008881:phosphocellulose; D000242:Cyclic AMP; D002118:Calcium